Heat, Fatigue, Medications, and Stress: The Oft-Missed Causes of Workplace Impairment

This blog was sponsored by Impairment Science Inc. Impairment Science's app, DRUID, assesses workers' fitness for duty by detecting and measuring cognitive and motor impairment, thereby reducing incidents, accidents, and injuries, saving lives, and boosting productivity.  

When most people think about workplace impairment, they think about drugs and alcohol. That association is understandable. For decades, the industry has invested heavily in substance use testing programs, and those programs have delivered real, measurable results. But focusing exclusively on drugs and alcohol misses a significant portion of the impairment risk that employees and employers face every day.

Fatigue. Heat. Prescription medications. Stress. Each of these factors can impair an employee's ability to safely operate equipment, make sound decisions, and respond appropriately in high-risk situations, and yet they rarely trigger the same level of organizational urgency as a positive drug test. That gap in attention is costing companies. It may be costing lives.

Fatigue: The Invisible Impairment

Sleep deprivation and fatigue are among the most pervasive and underrecognized sources of workplace impairment. According to the National Safety Council, fatigue contributes directly to 13% of all workplace injuries. Thirty-seven percent of American workers are sleep-deprived, and two-thirds report having felt fatigued at work.

The performance effects are striking. Research shows that fatigue impairs cognitive function at a level equivalent to a blood alcohol content of 0.05%. Workers who are fatigued are three times more likely to be involved in a workplace accident than their well-rested colleagues. Employees working 12-hour shifts face a 37% higher injury risk compared to those on 8-hour schedules, and accident rates are 30% greater on night shifts than on day shifts.

Federal OSHA has formally identified fatigue as a workplace hazard, linking it to heart disease, musculoskeletal disorders, depression, sleep disorders, and the worsening of chronic illnesses such as diabetes. The data is clear: when workers are exhausted, they are impaired, regardless of what they have or have not consumed.

Heat: A Cognitive Hazard, Not Just a Physical One

Heat stress is increasingly recognized not just as a physical health risk but as a cognitive impairment risk. A comprehensive national analysis of 2023 OSHA data identified approximately 28,000 workplace injuries attributable to hot conditions. Injury rates begin rising at ambient temperatures of 80 to 85 degrees Fahrenheit and escalate sharply above 90 degrees.

The cognitive effects of heat are well-documented. Research on miners found that heat strain significantly impaired performance on serial reaction time tests, reduced accuracy on the Stroop test (a standard measure of cognitive interference), and compromised delayed memory recall. Additional studies confirm that heat exposure reduces vigilant attention, inhibits the ability to suppress automatic responses, and impairs verbal memory.

The National Institute for Occupational Safety and Health (NIOSH) has initiated expanded research specifically aimed at identifying the core body temperature threshold at which cognitive decline begins, as well as the patterns of heat exposure duration and intensity that most commonly affect worker performance. For employers in construction, manufacturing, agriculture, transportation, and energy, this is not a future concern. It is a present one.

Medications: The Impairment No One Wants to Discuss

Prescription and over-the-counter medications are a third source of impairment that traditional safety programs consistently fail to address.  

The numbers are striking. Sixty-seven percent of employers report concerns about prescription drug misuse in the workplace, a rate comparable to concerns about workplace violence. Eighty-six percent of employers believe that taking opioids, even as prescribed, can impair job performance, yet only 60% have policies that require employees to disclose opioid use to their employer.

The risk extends well beyond opioids. Benzodiazepines, antihistamines, muscle relaxants, sleep aids, and certain antidepressants can all affect reaction time, attention, coordination, and judgment. A NIOSH Science Blog analysis found that workers using prescription opioids and benzodiazepines are more likely to be involved in motor vehicle crashes and perform worse on tasks requiring psychomotor functioning, particularly during shift work.

Twenty-three percent of the U.S. workforce has used prescription medications non-medically. But even medically appropriate use can produce functional impairment. Employers who limit their impairment conversation to illicit substances are leaving a significant portion of risk unmanaged.

Stress and Emotional Distress: The Performance Disruptors

Stress is not a soft issue. Chronic workplace stress has been shown to impair working memory, attention, response inhibition, and cognitive flexibility. These are precisely the cognitive functions that matter most in safety-sensitive roles. Under stress, workers may become impulsive, experience cognitive overload, or make decisions more slowly and less accurately than they otherwise would.

Research published in Frontiers in Psychology found a direct relationship between work-related stress and diminished employee performance, noting that impaired emotional regulation under occupational stress predicts both anxiety and depressive symptomatology. Employees managing personal crises, grief, financial strain, or organizational uncertainty may present as functionally impaired even when they arrive to work substance-free.

Supervisors are often the first to notice these changes. An employee who is normally sharp but seems scattered, slow to react, or uncharacteristically error-prone may be experiencing stress-induced impairment that no traditional screening tool will detect.

Moving Beyond the Substance Use Model

The question this raises for employers is straightforward: how do you manage what you cannot test for with a workplace drug test?

Part of the answer lies in culture. Organizations that treat impairment as a human performance issue rather than a compliance checkbox are better positioned to identify and address risk regardless of its source. That means training supervisors to recognize behavioral and performance changes, establishing fitness-for-duty policies that address impairment broadly rather than narrowly, and building an environment where employees feel safe disclosing when they are not at their best.

Part of the answer also lies in technology. Objective, science-based impairment assessment tools now exist that measure actual cognitive and psychomotor performance rather than the presence or absence of specific substances. Whether the source is fatigue, heat, a medication interaction, or severe emotional distress, the result is measurable at the level of performance, where it matters most.

This kind of capability, integrated into comprehensive compliance and workforce screening programs, represents the next evolution in workplace safety strategy. Together, these solutions moves organizations from reactive, substance-specific detection toward proactive, cause-agnostic identification of human performance risk.

The Bottom Line

Workplace impairment is bigger, much bigger, than drugs and alcohol. It always has been. Fatigue impairs workers at a level equivalent to being legally drunk. Heat degrades cognitive function at temperatures millions of outdoor workers encounter on a routine basis. Prescription medications carry risks that most employers' policies do not fully address. And stress can render an otherwise capable employee unfit for duty without leaving any trace in a biological sample.

Employers who genuinely want to protect their people need to broaden both their definition of impairment and their toolkit for addressing it. The science is there. The technology is there. The only thing still catching up is the conversation.

How Impairment Science and DISA Global Solutions Can Help

DISA Global Solutions and Impairment Science, Inc. help safety-sensitive employers move beyond simply identifying substance use to evaluating whether an employee is fit to perform critical work safely.  

Impairment Science’s DRUID mobile application uses brief, performance-based tasks to assess cognitive and motor functions such as decision-making, reaction time, balance, hand-eye coordination, and divided attention. Because impairment may result from fatigue, alcohol, cannabis, medications, illness, injury, heat stress, or emotional distress, this broader approach can help employers recognize risks that traditional drug testing alone may not capture.

Combined with DISA’s established workforce-compliance and risk-management services, these capabilities give safety-sensitive organizations a practical way to strengthen fit-for-duty programs, address emerging concerns such as fatigue and cannabis-related impairment, reduce preventable incidents, and protect employees and the communities in which they operate.

About the Author

Nina M. French is a nationally recognized authority in drug and alcohol testing, workplace safety, impairment assessment, and regulatory compliance.  

Her experience spans every major component of workplace substance use testing, including specimen collection protocols, chain of custody, toxicology interpretation, impairment technologies, cannabis testing, and interpreting and applying DOT (49 CFR Part 40 and modal regulations), SAMHSA, and state non-DOT laws to policy development governing reasonable suspicion, post-accident, fitness-for-duty, roadside enforcement, and return-to-duty decision-making.  

She provides clear, defensible guidance rooted in scientific, technical, and regulatory understanding, supporting attorneys, employers, and agencies in matters involving compliance, defensibility, and workplace risk.